• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国非药物干预措施对新冠疫情及其他传染病的协同效益:一项基于大规模人群的观察性研究。

Co-benefits of nonpharmaceutical intervention against COVID-19 on infectious diseases in China: A large population-based observational study.

作者信息

Xiao Jianpeng, Dai Jiya, Hu Jianxiong, Liu Tao, Gong Dexin, Li Xing, Kang Min, Zhou Yan, Li Yihan, Quan Yi, He Guanhao, Zhong Ruoxi, Zhu Zhihua, Huang Qiong, Zhang Yingtao, Huang Jianhua, Du Qingfeng, Li Yan, Song Tie, Hu Wenbiao, Zhong Haojie, Ma Wenjun

机构信息

Guangdong Provincial Institute of Public Health, Guangzhou, 511430, China.

Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, 511430, China.

出版信息

Lancet Reg Health West Pac. 2021 Dec;17:100282. doi: 10.1016/j.lanwpc.2021.100282. Epub 2021 Oct 1.

DOI:10.1016/j.lanwpc.2021.100282
PMID:34611630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8484818/
Abstract

: Nonpharmaceutical interventions (NPIs) are public health measures that aim to suppress the transmission of infectious diseases, including border restrictions, quarantine and isolation, community management, social distancing, face mask usage, and personal hygiene. This research aimed to assess the co-benefits of NPIs against COVID-19 on notifiable infectious diseases (NIDs) in Guangdong Province, China. Based on NID data from the Notifiable Infectious Diseases Surveillance System in Guangdong, we first compared the incidence of NIDs during the emergency response period (weeks 4-53 of 2020) with those in the same period of 2015-2019 and then compared that with the expected incidence during the synchronous period of 2020 for each city by using a Bayesian structural time series model. A total of 514,341 cases of 39 types of NIDs were reported in Guangdong during the emergency response period in 2020, which decreased by 50·7% compared with the synchronous period during 2015-2019. It was estimated that the number of 39 NIDs during the emergency response in 2020 was 65·6% (95% credible interval [CI]: 64·0% - 68·2%) lower than expected, which means that 982,356 (95% CI: 913,443 - 1,105,170) cases were averted. The largest reduction (82·1%) was found for children aged 0-14 years. For different categories of NIDs, natural focal diseases and insect-borne infectious diseases had the greatest reduction (89·4%), followed by respiratory infectious diseases (87·4%), intestinal infectious diseases (59·4%), and blood-borne and sexually transmitted infections (18·2%). Dengue, influenza, and hand-foot-and-mouth disease were reduced by 99·3%, 95·1%, and 76·2%, respectively. Larger reductions were found in the regions with developed economies and a higher number of COVID-19 cases. NPIs against COVID-19 may have a large co-benefit on the prevention of other infectious diseases in Guangdong, China, and the effects have heterogeneity in populations, diseases, time and space. Key-Area Research and Development Program of Guangdong Province.

摘要

非药物干预措施(NPIs)是旨在抑制传染病传播的公共卫生措施,包括边境限制、检疫与隔离、社区管理、社交距离、佩戴口罩以及个人卫生。本研究旨在评估中国广东省针对新冠疫情采取的非药物干预措施对法定传染病(NIDs)的协同效益。基于广东省法定传染病监测系统的法定传染病数据,我们首先将应急响应期间(2020年第4 - 53周)法定传染病的发病率与2015 - 2019年同期的发病率进行比较,然后通过贝叶斯结构时间序列模型,将其与2020年同期各城市的预期发病率进行比较。2020年应急响应期间,广东省共报告了39种法定传染病病例514,341例,与2015 - 2019年同期相比下降了50.7%。据估计,2020年应急响应期间39种法定传染病的发病数比预期低65.6%(95%可信区间[CI]:64.0% - 68.2%),这意味着避免了982,356例(95%CI:913,443 - 1,105,170)发病。0 - 14岁儿童的发病数下降幅度最大(82.1%)。对于不同类别的法定传染病,自然疫源性疾病和虫媒传染病的下降幅度最大(89.4%),其次是呼吸道传染病(87.4%)、肠道传染病(59.4%)以及血源及性传播感染(18.2%)。登革热、流感和手足口病的发病数分别下降了99.3%、95.1%和76.2%。经济发达且新冠病例数较多的地区下降幅度更大。针对新冠疫情的非药物干预措施可能对中国广东省预防其他传染病具有较大的协同效益,且其效果在人群、疾病、时间和空间上存在异质性。广东省重点领域研发计划。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e2a/8495103/57c625e4501a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e2a/8495103/e6047399635d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e2a/8495103/f938a425bd6c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e2a/8495103/dec52c66db19/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e2a/8495103/57c625e4501a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e2a/8495103/e6047399635d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e2a/8495103/f938a425bd6c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e2a/8495103/dec52c66db19/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e2a/8495103/57c625e4501a/gr4.jpg

相似文献

1
Co-benefits of nonpharmaceutical intervention against COVID-19 on infectious diseases in China: A large population-based observational study.中国非药物干预措施对新冠疫情及其他传染病的协同效益:一项基于大规模人群的观察性研究。
Lancet Reg Health West Pac. 2021 Dec;17:100282. doi: 10.1016/j.lanwpc.2021.100282. Epub 2021 Oct 1.
2
The indirect impacts of nonpharmacological COVID-19 control measures on other infectious diseases in Yinchuan, Northwest China: a time series study.中国西北银川市非药物 COVID-19 控制措施对其他传染病的间接影响:一项时间序列研究。
BMC Public Health. 2023 Jun 6;23(1):1089. doi: 10.1186/s12889-023-15878-3.
3
Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19.中国在 COVID-19 防控措施下传染病报告发病率的变化。
Front Public Health. 2021 Oct 15;9:728768. doi: 10.3389/fpubh.2021.728768. eCollection 2021.
4
Persistence and Variation of the Indirect Effects of COVID-19 Restrictions on the Spectrum of Notifiable Infectious Diseases in China: Analysis of National Surveillance Among Children and Adolescents From 2018 to 2021.COVID-19 限制措施对中国法定传染病谱的间接影响的持续性和变化:2018 年至 2021 年对儿童和青少年进行的全国监测分析。
JMIR Public Health Surveill. 2024 May 15;10:e47626. doi: 10.2196/47626.
5
The impact of COVID-19 on the epidemiology of non-airborne/droplet-transmitted notifiable infectious diseases in Taiwan: A descriptive study.COVID-19 对台湾非空气传播/飞沫传播传染病流行病学的影响:描述性研究。
J Infect Public Health. 2022 Sep;15(9):1001-1005. doi: 10.1016/j.jiph.2022.08.001. Epub 2022 Aug 4.
6
Effects of different levels of non-pharmaceutical interventions on hand, foot and mouth disease in Guangzhou, China.不同级别非药物干预措施对中国广州手足口病的影响。
BMC Public Health. 2022 Dec 20;22(1):2398. doi: 10.1186/s12889-022-14850-x.
7
The impact of anti-COVID-19 nonpharmaceutical interventions on hand, foot, and mouth disease-A spatiotemporal perspective in Xi'an, northwestern China.抗新冠病毒非药物干预措施对中国西北部西安市手足口病的影响:时空视角。
J Med Virol. 2022 Jul;94(7):3121-3132. doi: 10.1002/jmv.27715. Epub 2022 Mar 22.
8
Temporal shifts in 24 notifiable infectious diseases in China before and during the COVID-19 pandemic.中国 COVID-19 大流行前后 24 种法定传染病的时间变化。
Nat Commun. 2024 May 8;15(1):3891. doi: 10.1038/s41467-024-48201-8.
9
Trends and disparities in 44 national notifiable infectious diseases in China: An analysis of national surveillance data from 2010 to 2019.中国 44 种法定传染病的流行趋势和差异:基于 2010 年至 2019 年国家监测数据的分析。
J Med Virol. 2023 Jan;95(1):e28353. doi: 10.1002/jmv.28353.
10
Different Transmission Dynamics of Coronavirus Disease 2019 (COVID-19) and Influenza Suggest the Relative Efficiency of Isolation/Quarantine and Social Distancing Against COVID-19 in China.不同的 2019 年冠状病毒病(COVID-19)和流感的传播动力学表明,中国针对 COVID-19 的隔离/检疫和社会隔离措施具有相对效率。
Clin Infect Dis. 2021 Dec 6;73(11):e4305-e4311. doi: 10.1093/cid/ciaa1584.

引用本文的文献

1
Epidemiological characteristics of acute respiratory infectious diseases in the first year after COVID-19 pandemic in Guangdong Province, China.中国广东省新冠疫情大流行后第一年急性呼吸道传染病的流行病学特征
Respir Res. 2025 Jul 2;26(1):222. doi: 10.1186/s12931-025-03308-4.
2
Epidemiological Characteristics and Trends of Zoonotic Diseases in China from 2015 to 2022.2015年至2022年中国动物源性疾病的流行病学特征与趋势
Trop Med Infect Dis. 2025 Jun 9;10(6):159. doi: 10.3390/tropicalmed10060159.
3
Changes in Epidemiological Characteristics of Varicella and Breakthrough Cases in Ningbo, China, From 2010 to 2023: Surveillance Study.

本文引用的文献

1
Impact of COVID-19 on the travel and tourism industry.新冠疫情对旅游行业的影响。
Technol Forecast Soc Change. 2021 Feb;163:120469. doi: 10.1016/j.techfore.2020.120469. Epub 2020 Nov 16.
2
The impact of the coronavirus disease 2019 epidemic on notifiable infectious diseases in Taiwan: A database analysis.2019 年冠状病毒病疫情对台湾法定传染病的影响:数据库分析。
Travel Med Infect Dis. 2021 Mar-Apr;40:101997. doi: 10.1016/j.tmaid.2021.101997. Epub 2021 Feb 25.
3
Observed impacts of the COVID-19 pandemic on global trade.
2010年至2023年中国宁波水痘及突破性病例的流行病学特征变化:监测研究
JMIR Public Health Surveill. 2025 Jun 18;11:e71691. doi: 10.2196/71691.
4
Time series analysis and scaling law characteristics of viral hepatitis from 2004 to 2023 in Zhejiang Province, China.2004年至2023年中国浙江省病毒性肝炎的时间序列分析及标度律特征
PLoS One. 2025 Mar 10;20(3):e0319642. doi: 10.1371/journal.pone.0319642. eCollection 2025.
5
Temporal shifts in dengue epidemic in Guangdong Province before and during the COVID-19 pandemic: a Bayesian model study from 2012 to 2022.COVID-19大流行之前及期间广东省登革热疫情的时间变化:一项2012年至2022年的贝叶斯模型研究
PLoS Negl Trop Dis. 2025 Feb 3;19(2):e0012832. doi: 10.1371/journal.pntd.0012832. eCollection 2025 Feb.
6
Long-term impact of COVID-19-related nonpharmaceutical interventions on tuberculosis: an interrupted time series analysis using Bayesian method.2019冠状病毒病相关非药物干预措施对结核病的长期影响:一项使用贝叶斯方法的中断时间序列分析
J Glob Health. 2025 Jan 24;15:04012. doi: 10.7189/jogh.15.04012.
7
Interrupted time series analysis to evaluate the impact of COVID-19-pandemic on the incidence of notifiable infectious diseases in the Lazio region, Italy.中断时间序列分析,以评估COVID-19大流行对意大利拉齐奥地区法定传染病发病率的影响。
BMC Public Health. 2025 Jan 13;25(1):132. doi: 10.1186/s12889-024-21256-4.
8
Trend of hand, foot and mouth disease before, during, and after China's COVID control policies in Zhejiang, China.中国浙江在实施新冠疫情防控政策之前、期间及之后手足口病的发病趋势
Front Public Health. 2024 Nov 19;12:1472944. doi: 10.3389/fpubh.2024.1472944. eCollection 2024.
9
Impact of non-pharmacological interventions on incidence of hand, foot and mouth disease during the COVID-19 pandemic: a large population-based observational study.非药物干预对 COVID-19 大流行期间手足口病发病率的影响:一项基于人群的大型观察性研究。
BMC Infect Dis. 2024 Nov 27;24(1):1353. doi: 10.1186/s12879-024-10252-z.
10
Impact of COVID-19 Interventions on Respiratory and Intestinal Infectious Disease Notifications - Jiangsu Province, China, 2020-2023.2020 - 2023年中国江苏省新冠疫情防控措施对呼吸道及肠道传染病报告的影响
China CDC Wkly. 2024 Oct 11;6(41):1059-1064. doi: 10.46234/ccdcw2024.219.
新冠疫情对全球贸易的观察影响。
Nat Hum Behav. 2021 Mar;5(3):305-307. doi: 10.1038/s41562-021-01060-5. Epub 2021 Feb 25.
4
Excess mortality in Wuhan city and other parts of China during the three months of the covid-19 outbreak: findings from nationwide mortality registries.新冠疫情爆发三个月期间武汉市及中国其他地区的超额死亡率:全国死因登记系统的研究结果。
BMJ. 2021 Feb 24;372:n415. doi: 10.1136/bmj.n415.
5
Integrated vaccination and physical distancing interventions to prevent future COVID-19 waves in Chinese cities.综合疫苗接种和身体距离干预措施,以预防中国城市未来的 COVID-19 浪潮。
Nat Hum Behav. 2021 Jun;5(6):695-705. doi: 10.1038/s41562-021-01063-2. Epub 2021 Feb 18.
6
Impact of COVID-19 preventive measures on other infectious and non-infectious respiratory diseases in Pakistan.2019冠状病毒病预防措施对巴基斯坦其他传染性和非传染性呼吸道疾病的影响。
J Infect. 2021 May;82(5):e31-e32. doi: 10.1016/j.jinf.2021.01.018. Epub 2021 Jan 29.
7
Assessing the future progression of COVID-19 in Iran and its neighbors using Bayesian models.使用贝叶斯模型评估伊朗及其邻国新冠病毒病的未来发展情况。
Infect Dis Model. 2021;6:343-350. doi: 10.1016/j.idm.2021.01.005. Epub 2021 Jan 22.
8
Prevalence and Risk Factors Associated With Self-reported Psychological Distress Among Children and Adolescents During the COVID-19 Pandemic in China.新冠疫情期间中国儿童和青少年自我报告心理困扰的流行状况及相关风险因素。
JAMA Netw Open. 2021 Jan 4;4(1):e2035487. doi: 10.1001/jamanetworkopen.2020.35487.
9
The time-varying transmission dynamics of COVID-19 and synchronous public health interventions in China.中国 COVID-19 的时变传播动力学与同步公共卫生干预措施。
Int J Infect Dis. 2021 Feb;103:617-623. doi: 10.1016/j.ijid.2020.11.005. Epub 2020 Nov 9.
10
Protecting the most vulnerable from hand, foot, and mouth disease.保护最弱势群体免受手足口病侵害。
Lancet Infect Dis. 2021 Mar;21(3):308-309. doi: 10.1016/S1473-3099(20)30452-7. Epub 2020 Oct 5.